A randomized, double-blind, placebo-controlled, multicenter study of rabbit ATG in the prophylaxis of acute rejection in lung transplantation

American Journal of Transplantation

Volumn 14, Issue 5, 2014, Pages 1191-1198

  Snell, G I ^a   Westall, G P ^a   Levvey, B J ^a   Jaksch, P ^b   Keshavjee, S ^c   Hoopes, C W ^d   Ahya, V ^e   Mehta, A ^f   Trulock III, E P ^g  

^a ALFRED HOSPITAL   (Australia)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute rejection; alloreactivity; induction immunosuppression; lung transplantation; rabbit ATG

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY;

ADULT; ANIMAL; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GRAFT REJECTION; HUMAN; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PROGNOSIS; PROSPECTIVE STUDY; RABBIT; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANIMALS; ANTILYMPHOCYTE SERUM; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RABBITS;

EID: 84899440668     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12663     Document Type: Article

References (20)

1. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310.
2. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007; 26: 1229-1242.
3. van den Hoogen MW, Hoitsma AJ, Hilbrands LB., Anti-T-cell antibodies for the treatment of acute rejection after renal transplantation. Expert Opin Biol Ther 2012; 12: 1031-1042.
4. Shenoy M, Roberts D, Plant ND, Lewis MA, Webb NJ., Antithymocyte treatment of steroid-resistant acute rejection in renal transplantation. Pediatr Nephrol 2011; 26: 815-818.
5. Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant 2012; 31: 1073-1086.
6. Treede H, Glanville AR, Klepetko W, et al. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: Results of a prospective, randomized international trial in lung transplantation. J Heart Lung Transplant 2012; 31: 797-804.
7. Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth adult lung and heart-lung transplant report-2011. J Heart Lung Transplant 2011; 30: 1104-1122.
8. Jaksch P, Wiedemann D, Augustin V, et al. Antithymocyte globulin induction therapy improves survival in lung transplantation for cystic fibrosis. Transpl Int 2013; 26: 34-41.
9. Griffith BP, Hardesty RL, Armitage JM, et al. Acute rejection of lung allografts with various immunosuppressive protocols. Ann Thorac Surg 1992; 54: 846-851.
10. Palmer SM, Miralles AP, Lawrence CM, Gaynor JW, Davis RD, Tapson VF., Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: Results of a randomized, prospective study. Chest 1999; 116: 127-133.
11. Garrity ER Jr, Villanueva J, Bhorade SM, Husain AN, Vigneswaran WT., Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody. Transplantation 2001; 71: 773-777.
12. ATG-Fresenius S SoPCSGe, Version 2010-2012. Fresenius Biotech, Munich, Germany.
13. Kaden J, May G, Volp A, Wesslau C., Factors impacting short and long-term kidney graft survival: Modification by single intra-operative-high-dose induction with ATG-Fresenius. Ann Transplant 2011; 16: 81-91.
14. van den Hoogen MW, Kho MM, Abrahams AC, et al. Effect of a single intraoperative high-dose ATG-Fresenius on delayed graft function in donation after cardiac-death donor renal allograft recipients: A randomized study. Exp Clin Transplant 2013; 11: 134-141.
15. Kyllonen LE, Eklund BH, Pesonen EJ, Salmela KT., Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: Efficacy and safety. Transplantation 2007; 84: 75-82.
16. Bugelski PJ, Achuthanandam R, Capocasale RJ, Treacy G, Bouman-Thio E., Monoclonal antibody-induced cytokine-release syndrome. Expert Rev Clin Immunol 2009; 5: 499-521.
17. Cui L, Hung HM, Wang SJ., Modification of sample size in group sequential clinical trials. Biometrics 1999; 55: 853-857.
18. Hartwig MG, Snyder LD, Appel JZ III, et al. Rabbit anti-thymocyte globulin induction therapy does not prolong survival after lung transplantation. J Heart Lung Transplant 2008; 27: 547-553.
19. Keenan RJ, Konishi H, Kawai A, et al. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg 1995; 60: 580-584, discussion 584-585. Epub September 1, 1995.
20. Zuckermann A, Reichenspurner H, Birsan T, et al. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: One-year results of a 2-center prospective randomized trial. J Thorac Cardiovasc Surg 2003; 125: 891-900.